 | | PRD_000264 | | Name: | N-(tert-butoxycarbonyl)-L-phenylalanyl-N-{(1S)-1-[(R)-hydroxy(2-{[(2S)-2-methylbutyl]amino}-2-oxoethyl)phosphoryl]-3-methylbutyl}-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | | Formula: | C32 H52 N6 O7 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000265 | | Name: | (2S)-2-[[(3S,4S)-5-cyclohexyl-4-[[(4S,5S)-5-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxidanyl-6-phenyl-hexanoyl]amino]
-3-oxidanyl-pentanoyl]amino]-4-methyl-pentanoic acid | | Formula: | C34 H55 N3 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000266 | | Formula: | C52 H81 N11 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000267 | | Name: | H-261 Oligopeptide | | Formula: | C55 H84 N13 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000268 | | Name: | L-364,099 | | Formula: | C54 H77 N11 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000269 | | Name: | [1-BENZYL-3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA-1(16),13(17),14-TRIEN-11-YLAMINO)-2-HYDROXY-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER | | Formula: | C33 H48 N4 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000270 | | Name: | 4-biphenylacetyl-CYS-(D)ARG-TYR-N-(2-phenylethyl) amide | | Formula: | C40 H49 N7 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000271 | | Name: | N-[(benzyloxy)carbonyl]-L-isoleucyl-N-[(1R)-1-(carboxycarbonyl)-3,3-difluoropropyl]-L-leucinamide | | Formula: | C25 H35 F2 N3 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000272 | | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | | Formula: | C34 H50 N7 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000275 | | Name: | Ac-DADE-F(2)Pmp-L-NH(2) | | Formula: | C32 H46 F2 N7 O15 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000276 | | Name: | Thrombostatin FM inhibitor [rOicPaF(p-Me)] | | Formula: | C33 H52 N9 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000277 | | Name: | N-[(benzyloxy)carbonyl]-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]-L-valinamide | | Formula: | C27 H35 Cl N4 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000278 | | Name: | DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE | | Formula: | C34 H71 Cl N11 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000279 | | Name: | D-leucyl-N-(4-fluorobenzyl)-L-phenylalaninamide | | Formula: | C22 H28 F N3 O2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000280 | | Name: | HIV ENTRY INHIBITOR PIE1 | | Formula: | C80 H118 N22 O22 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000281 | | Name: | HIV ENTRY INHIBITOR PIE7 | | Formula: | C81 H110 N20 O22 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000282 | | Name: | N-acetyl-L-alpha-aspartyl-L-asparaginyl-N-[(1R)-2-carboxy-1-formylethyl]-L-leucinamide | | Formula: | C20 H33 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000283 | | Name: | N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-{[(1R)-1-phenylpropyl]amino}butan-2-yl]-N~4~,N~4~-dimethyl-L-aspartamide | | Formula: | C37 H63 N7 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000284 | | Name: | AC-DQMD-CHO | | Formula: | C20 H33 N5 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000285 | | Name: | L-tryptophyl-L-tyrosyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-threoninamide | | Formula: | C31 H44 Cl N8 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000286 | | Name: | D-valyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-L-leucinamide | | Formula: | C18 H36 Cl N4 O3 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000287 | | Name: | N-{[5-(dimethylamino)naphthalen-1-yl]sulfonyl}-L-alpha-glutamyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]glycinamide | | Formula: | C26 H38 Cl N7 O7 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000288 | | Name: | L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]amino}-1-[(1S)-2-chloro-1-hydroxyethyl]butyl}glycinamide | | Formula: | C14 H28 Cl N6 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000289 | | Name: | BETA-SECRETASE INHIBITOR OM00-3 | | Formula: | C44 H69 N7 O15 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000290 | | Name: | BETA-SECRETASE INHIBITOR OM99-2 | | Formula: | C41 H64 N8 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
